NewLink Genetics (NLNK)

Add to Watchlists Create an Alert
26.22 -0.77  -2.85% NASDAQ Sep 18, 11:44AM BATS Real time Currency in USD
View Full Chart
NLNK Price Chart
View All Events

NLNK Events

Date Type Description
08/05/2014 Earnings NewLink Genetics Corporation Reports Second Quarter 2014 Financial Results
05/06/2014 Earnings NewLink Genetics Corp 1Q2014 Earning Result
05/01/2014 09:00 EDT Misc AGM Event for NewLink Genetics Corp
05/01/2014 Misc Annual General Meeting for NewLink Genetics Corp
03/11/2014 16:30 EDT Misc Q4 2013 NewLink Genetics Corp Earnings Conference Call
03/11/2014 Earnings Q4 2013 NewLink Genetics Corp Earnings Results
11/12/2013 Earnings NewLink Genetics Corporation Reports Third Quarter 2013 Financial Results
View All Performance Charts

NLNK Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). NewLink Genetics is up 49.74% over the last year vs S&P 500 Total Return up 20.36%, Biocryst Pharmaceuticals up 71.89%, and Sarepta Therapeutics down 39.57%.

Get Quote for
Advertisement

Portfolio Strategies Featuring NLNK

Did NewLink Genetics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

NLNK Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.linkp.com
  • IR Website: http://investors.linkp.com/
  • HQ Country: United States
  • HQ State/Province: Iowa
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

NewLink Genetics Corp., is a biopharmaceutical company. It focuses on discovering, developing and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians.

NLNK Excel Add-In Codes

  • Name: =YCI("NLNK","name")
  • Description: =YCI("NLNK","description")
  • Sector: =YCI("NLNK","sector")
  • Industry: =YCI("NLNK","industry")
  • Est. Current Fiscal Year End: =YCI("NLNK","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.